1 |
Stockinger, B. 2007. Good for Goose, but not for Gander: IL-2 interferes with Th17 differentiation. Immunity 26: 278-279
DOI
|
2 |
Visekruna, A., M. Huber, A. Hellhund, E. Bothur, K. Reinhard, N. Bollig, N. Schmidt, T. Joeris, M. Lohoff, and U. Steinhoff. 2010. c-Rel is crucial for the induction of Foxp3(+) regulatory CD4(+) T cells but not T(H)17 cells. Eur. J. Immunol. 40: 671-676.
DOI
|
3 |
Liu, X., H. Li, B. Zhong, M. Blonska, S. Gorjestani, M. Yan, Q. Tian, D. E. Zhang, X. Lin, and C. Dong. 2013. USP18 inhibits NF-kappaB and NFAT activation during Th17 differentiation by deubiquitinating the TAK1-TAB1 complex. J. Exp. Med. 210: 1575-1590.
DOI
|
4 |
Khayrullina, T., J. H. Yen, H. Jing, and D. Ganea. 2008. In vitro differentiation of dendritic cells in the presence of prostaglandin E2 alters the IL-12/IL-23 balance and promotes differentiation of Th17 cells. J. Immunol. 181: 721-735.
DOI
|
5 |
Ruan, Q., V. Kameswaran, Y. Zhang, S. Zheng, J. Sun, J. Wang, J. DeVirgiliis, H. C. Liou, A. A. Beg, and Y. H. Chen. 2011. The Th17 immune response is controlled by the Rel-RORgamma-RORgamma T transcriptional axis. J. Exp. Med. 208: 2321-2333.
DOI
|
6 |
Kwon, M. J., J. Ma, Y. Ding, R. Wang, and Z. Sun. 2012. Protein kinase C-theta promotes Th17 differentiation via upregulation of Stat3. J. Immunol. 188: 5887-5897.
DOI
|
7 |
Brustle, A., D. Brenner, C. B. Knobbe, P. A. Lang, C. Virtanen, B. M. Hershenfield, C. Reardon, S. M. Lacher, J. Ruland, P. S. Ohashi, and T. W. Mak. 2012. The NF-kappaB regulator MALT1 determines the encephalitogenic potential of Th17 cells. J. Clin. Invest. 122: 4698-4709.
DOI
|
8 |
Molinero, L. L., A. Cubre, C. Mora-Solano, Y. Wang, and M. L. Alegre. 2012. T cell receptor/CARMA1/NF-kappaB signaling controls T-helper (Th) 17 differentiation. Pro. Natl. Acad. Sci. USA 109: 18529-18534.
DOI
|
9 |
Iguchi-Hashimoto, M., T. Usui, H. Yoshifuji, M. Shimizu, S. Kobayashi, Y. Ito, K. Murakami, A. Shiomi, N. Yukawa, D. Kawabata, T. Nojima, K. Ohmura, T. Fujii, and T. Mimori. 2011. Overexpression of a minimal domain of calpastatin suppresses IL-6 production and Th17 development via reduced NF-kappaB and increased STAT5 signals. PloS one 6: e27020.
DOI
|
10 |
Okamoto, K., Y. Iwai, M. Oh-Hora, M. Yamamoto, T. Morio, K. Aoki, K. Ohya, A. M. Jetten, S. Akira, T. Muta, and H. Takayanagi. 2010. IkappaBzeta regulates T(H)17 development by cooperating with ROR nuclear receptors. Nature 464: 1381-1385.
DOI
ScienceOn
|
11 |
Glas, J., J. Stallhofer, S. Ripke, M. Wetzke, S. Pfennig, W. Klein, J. T. Epplen, T. Griga, U. Schiemann, M. Lacher, S. Koletzko, M. Folwaczny, P. Lohse, B. Goke, T. Ochsenkuhn, B. Muller-Myhsok, and S. Brand. 2009. Novel genetic risk markers for ulcerative colitis in the IL2/IL21 region are in epistasis with IL23R and suggest a common genetic background for ulcerative colitis and celiac disease. Am. J. Gastroenterol. 104: 1737-1744.
DOI
|
12 |
Monteleone, G., I. Monteleone, D. Fina, P. Vavassori, G. Del Vecchio Blanco, R. Caruso, R. Tersigni, L. Alessandroni, L. Biancone, G. C. Naccari, T. T. MacDonald, and F. Pallone. 2005. Interleukin-21 enhances T-helper cell type I signaling and interferon-gamma production in Crohn's disease. Gastroenterology 128: 687-694.
DOI
ScienceOn
|
13 |
Sarra, M., I. Monteleone, C. Stolfi, M. C. Fantini, P. Sileri, G. Sica, R. Tersigni, T. T. Macdonald, F. Pallone, and G. Monteleone. 2010. Interferon-gamma-expressing cells are a major source of interleukin-21 in inflammatory bowel diseases. Inflamm. Bowel Dis. 16: 1332-1339.
DOI
|
14 |
Stolfi, C., A. Rizzo, E. Franze, A. Rotondi, M. C. Fantini, M. Sarra, R. Caruso, I. Monteleone, P. Sileri, L. Franceschilli, F. Caprioli, S. Ferrero, T. T. MacDonald, F. Pallone, and G. Monteleone. 2011. Involvement of interleukin-21 in the regulation of colitis-associated colon cancer. J. Exp. Med. 208: 2279-2290.
DOI
ScienceOn
|
15 |
Ouaaz, F., J. Arron, Y. Zheng, Y. Choi, and A. A. Beg. 2002. Dendritic cell development and survival require distinct NF-kappaB subunits. Immunity 16: 257-270.
DOI
ScienceOn
|
16 |
Kotake, S., N. Udagawa, N. Takahashi, K. Matsuzaki, K. Itoh, S. Ishiyama, S. Saito, K. Inoue, N. Kamatani, M. T. Gillespie, T. J. Martin, and T. Suda. 1999. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Invest. 103: 1345-1352.
DOI
ScienceOn
|
17 |
O'Keeffe, M., R. J. Grumont, H. Hochrein, M. Fuchsberger, R. Gugasyan, D. Vremec, K. Shortman, and S. Gerondakis. 2005. Distinct roles for the NF-kappaB1 and c-Rel transcription factors in the differentiation and survival of plasmacytoid and conventional dendritic cells activated by TLR-9 signals. Blood 106: 3457-3464.
DOI
|
18 |
Gerondakis, S. and U. Siebenlist. 2010. Roles of the NF-kappaB pathway in lymphocyte development and function. Cold Spring Harb. Perspect. Biol. 2: a000182.
|
19 |
Park, S. G., R. Mathur, M. Long, N. Hosh, L. Hao, M. S. Hayden, and S. Ghosh. 2010. T regulatory cells maintain intestinal homeostasis by suppressing gammadelta T cells. Immunity 33: 791-803.
DOI
ScienceOn
|
20 |
Wong, C. K., C. Y. Ho, F. W. Ko, C. H. Chan, A. S. Ho, D. S. Hui, and C. W. Lam. 2001. Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-gamma, IL-4, IL-10 and IL-13) in patients with allergic asthma. Clin. Exp. Immunol. 125: 177-183.
DOI
ScienceOn
|
21 |
Kim, S. W., E. S. Kim, C. M. Moon, J. J. Park, T. I. Kim, W. H. Kim, and J. H. Cheon. 2011. Genetic polymorphisms of IL-23R and IL-17A and novel insights into their associations with inflammatory bowel disease. Gut 60: 1527-1536.
DOI
ScienceOn
|
22 |
Zhou, L., I. I. Ivanov, R. Spolski, R. Min, K. Shenderov, T. Egawa, D. E. Levy, W. J. Leonard, and D. R. Littman. 2007. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8: 967-974.
DOI
ScienceOn
|
23 |
Dong, C. 2008. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat. Rev. Immunol. 8: 337-348.
DOI
ScienceOn
|
24 |
Kobayashi, T., S. Okamoto, T. Hisamatsu, N. Kamada, H. Chinen, R. Saito, M. T. Kitazume, A. Nakazawa, A. Sugita, K. Koganei, K. Isobe, and T. Hibi. 2008. IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease. Gut 57: 1682-1689.
DOI
ScienceOn
|
25 |
Littman, D. R. and A. Y. Rudensky. 2010. Th17 and regulatory T cells in mediating and restraining inflammation. Cell 140: 845-858.
DOI
|
26 |
Fujino, S., A. Andoh, S. Bamba, A. Ogawa, K. Hata, Y. Araki, T. Bamba, and Y. Fujiyama. 2003. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52: 65-70.
DOI
ScienceOn
|
27 |
Zhang, Z., M. Zheng, J. Bindas, P. Schwarzenberger, and J. K. Kolls. 2006. Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm. Bowel Dis. 12: 382-388.
DOI
ScienceOn
|
28 |
Chen, Z., C. M. Tato, L. Muul, A. Laurence, and J. J. O'Shea. 2007. Distinct regulation of interleukin-17 in human T helper lymphocytes. Arthritis Rheum. 56: 2936-2946.
DOI
|
29 |
Harrington, L. E., R. D. Hatton, P. R. Mangan, H. Turner, T. L. Murphy, K. M. Murphy, and C. T. Weaver. 2005. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6: 1123-1132.
DOI
ScienceOn
|
30 |
El-Behi, M., B. Ciric, H. Dai, Y. Yan, M. Cullimore, F. Safavi, G. X. Zhang, B. N. Dittel, and A. Rostami. 2011. The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat. Immunol. 12: 568-575.
DOI
|
31 |
Park, H., Z. Li, X. O. Yang, S. H. Chang, R. Nurieva, Y. H. Wang, Y. Wang, L. Hood, Z. Zhu, Q. Tian, and C. Dong. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6: 1133-1141.
DOI
ScienceOn
|
32 |
Kramer, J. M. and S. L. Gaffen. 2007. Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy. J. Periodontol. 78: 1083-1093.
DOI
|
33 |
Kaser, A., S. Zeissig, and R. S. Blumberg. 2010. Inflammatory bowel disease. Annu. Rev. Immunol. 28: 573-621.
DOI
ScienceOn
|
34 |
Chebotar, I. V., M. I. Zaslavskaia, T. M. Konyshkina, and A. N. Maianskii. 1991. IgG- and C3-dependent adhesion of neutrophils in systems with allogeneic and xenogeneic ligands. Biull. Eksp. Biol. Med. 112: 403-404.
|
35 |
Chuang, H. C., J. L. Lan, D. Y. Chen, C. Y. Yang, Y. M. Chen, J. P. Li, C. Y. Huang, P. E. Liu, X. Wang, and T. H. Tan. 2011. The kinase GLK controls autoimmunity and NF-kappaB signaling by activating the kinase PKC-theta in T cells. Nat. Immunol. 12: 1113-1118.
DOI
|
36 |
Xavier, R. J. and D. K. Podolsky. 2007. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448: 427-434.
DOI
ScienceOn
|
37 |
Dodson, L. F., J. S. Boomer, C. M. Deppong, D. D. Shah, J. Sim, T. L. Bricker, J. H. Russell, and J. M. Green. 2009. Targeted knock-in mice expressing mutations of CD28 reveal an essential pathway for costimulation. Mol Cell Biol. 29: 3710-3721.
DOI
|
38 |
Kang, J. A., S. P. Jeong, D. Park, M. S. Hayden, S. Ghosh, and S. G. Park. 2013. Transition from heterotypic to homotypic PDK1 homodimerization is essential for TCR-mediated NF-kappaB activation. J. Immunol. 190: 4508-4515.
DOI
|
39 |
Romagnani, S. 1994. Lymphokine production by human T cells in disease states. Annu. Rev. Immunol. 12: 227-257.
DOI
ScienceOn
|
40 |
Korn, T., E. Bettelli, M. Oukka, and V. K. Kuchroo. 2009. IL-17 and Th17 Cells. Annu. Rev. Immunol. 27: 485-517.
DOI
ScienceOn
|
41 |
Ahern, P. P., A. Izcue, K. J. Maloy, and F. Powrie. 2008. The interleukin-23 axis in intestinal inflammation. Immunol. Rev. 226: 147-159.
DOI
ScienceOn
|
42 |
Cua, D. J. and C. M. Tato. 2010. Innate IL-17-producing cells: the sentinels of the immune system. Nat. Rev. Immunol. 10: 479-489.
DOI
ScienceOn
|
43 |
Laurence, A. and J. J. O'Shea. 2007. T(H)-17 differentiation: of mice and men. Nat. Immunol. 8: 903-905.
DOI
ScienceOn
|
44 |
Acosta-Rodriguez, E. V., G. Napolitani, A. Lanzavecchia, and F. Sallusto. 2007. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8: 942-949.
|
45 |
Pagan, A. J., M. Pepper, H. H. Chu, J. M. Green, and M. K. Jenkins. 2012. CD28 promotes CD4+ T cell clonal expansion during infection independently of its YMNM and PYAP motifs. J. Immunol. 189: 2909-2917.
DOI
|
46 |
Yokosuka, T., W. Kobayashi, K. Sakata-Sogawa, M. Takamatsu, A. Hashimoto-Tane, M. L. Dustin, M. Tokunaga, and T. Saito. 2008. Spatiotemporal regulation of T cell costimulation by TCR-CD28 microclusters and protein kinase C theta translocation. Immunity 29: 589-601.
DOI
|
47 |
Park, S. G., J. Schulze-Luehrman, M. S. Hayden, N. Hashimoto, W. Ogawa, M. Kasuga, and S. Ghosh. 2009. The kinase PDK1 integrates T cell antigen receptor and CD28 coreceptor signaling to induce NF-kappaB and activate T cells. Nat. Immunol. 10: 158-166.
DOI
ScienceOn
|
48 |
Pages, F., M. Ragueneau, R. Rottapel, A. Truneh, J. Nunes, J. Imbert, and D. Olive. 1994. Binding of phosphatidylinositol- 3-OH kinase to CD28 is required for T-cell signalling. Nature 369: 327-329.
DOI
|
49 |
Narayan, P., B. Holt, R. Tosti, and L. P. Kane. 2006. CARMA1 is required for Akt-mediated NF-kappaB activation in T cells. Mol. Cell. Biol. 26: 2327-2336.
DOI
|
50 |
Matsumoto, R., D. Wang, M. Blonska, H. Li, M. Kobayashi, B. Pappu, Y. Chen, D. Wang, and X. Lin. 2005. Phosphorylation of CARMA1 plays a critical role in T Cell receptor-mediated NF-kappaB activation. Immunity 23: 575-585.
DOI
|
51 |
Garcon, F., D. T. Patton, J. L. Emery, E. Hirsch, R. Rottapel, T. Sasaki, and K. Okkenhaug. 2008. CD28 provides T-cell costimulation and enhances PI3K activity at the immune synapse independently of its capacity to interact with the p85/p110 heterodimer. Blood 111: 1464-1471.
|
52 |
Hayden, M. S. and S. Ghosh. 2004. Signaling to NF-kappaB. Genes Dev. 18: 2195-2224.
DOI
ScienceOn
|
53 |
Hayden, M. S. and S. Ghosh. 2011. NF-kappaB in immunobiology. Cell Res. 21: 223-244.
DOI
ScienceOn
|
54 |
Hayden, M. S., A. P. West, and S. Ghosh. 2006. NF-kappaB and the immune response. Oncogene 25: 6758-6780.
DOI
ScienceOn
|
55 |
Kane, L. P., J. Lin, and A. Weiss. 2002. It's all Rel-ative: NF-kappaB and CD28 costimulation of T-cell activation. Trends Immunol. 23: 413-420.
DOI
|
56 |
Schulze-Luehrmann, J. and S. Ghosh. 2006. Antigen-receptor signaling to nuclear factor kappa B. Immunity 25: 701-715.
DOI
|
57 |
Oh, H. and S. Ghosh. 2013. NF-kappaB: roles and regulation in different CD4(+) T-cell subsets. Immunol. Rev. 252: 41-51.
DOI
|
58 |
Alegre, M. L., K. A. Frauwirth, and C. B. Thompson. 2001. T-cell regulation by CD28 and CTLA-4. Nat. Rev. Immunol. 1: 220-228.
|
59 |
Frauwirth, K. A., J. L. Riley, M. H. Harris, R. V. Parry, J. C. Rathmell, D. R. Plas, R. L. Elstrom, C. H. June, and C. B. Thompson. 2002. The CD28 signaling pathway regulates glucose metabolism. Immunity 16: 769-777.
DOI
ScienceOn
|
60 |
Wong, C. K., L. C. Lit, L. S. Tam, E. K. Li, P. T. Wong, and C. W. Lam. 2008. Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. Clin. Immunol. 127: 385-393.
DOI
ScienceOn
|
61 |
Cooke, A. 2006. Th17 cells in inflammatory conditions. Rev. Diabet. Stud. 3: 72-75.
DOI
|
62 |
Villalba, M., K. Bi, J. Hu, Y. Altman, P. Bushway, E. Reits, J. Neefjes, G. Baier, R. T. Abraham, and A. Altman. 2002. Translocation of PKC[theta] in T cells is mediated by a nonconventional, PI3-K- and Vav-dependent pathway, but does not absolutely require phospholipase C. J. Cell Biol. 157: 253-263.
DOI
ScienceOn
|
63 |
Sanchez-Lockhart, M., E. Marin, B. Graf, R. Abe, Y. Harada, C. E. Sedwick, and J. Miller. 2004. Cutting edge: CD28-mediated transcriptional and posttranscriptional regulation of IL-2 expression are controlled through different signaling pathways. J. Immunol. 173: 7120-7124.
DOI
|